Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

733 ARTÍCULOS , VIENDO DEL 181 AL 195

Sigma-1 Receptor Ligand Blarcamesine (ANAVEX 2-73) for Alzheimer's Disease: A Systematic Review

Brimson S, Thitilertdecha P, Kumaree KK, Brimson JM.

CNS Drugs. 2026 Sep;40(9):1225-1241. doi: 10.1007/s40263-026-01327-3. Epub 2026 Aug 6.

Impact of Narrative Nursing and Cognitive Behavioral Rehabilitation on Cognitive Function and Anxiety in Patients With Alzheimer's Disease

Shao R, Li W, Su H, Zhou S, Lan M, Li D.

Geriatr Gerontol Int. 2026 Aug;26(8):e70719. doi: 10.1111/ggi.70719.

Discovery of Anti-Neuroinflammatory Compounds in Alzheimer's Disease: Current Trends and Future Perspectives

Paelaong N, Sripha K, Boondam Y.

Mol Neurobiol. 2026 Aug 8;63(1):819. doi: 10.1007/s12035-026-06114-1.

GLP-1 receptor agonists, metabolic syndrome, and Alzheimer's disease: Lessons and opportunities from the EVOKE trials

Gupta P, Pozzilli V, De Giovanni A, Sapio E, Motolese F, Capone F, Pozzilli P.

J Neuroendocrinol. 2026 Aug;38(8):e70246. doi: 10.1111/jne.70246.

Oxidative Stress in Alzheimer's Disease: Can Dietary Interventions Provide Neuroprotection?

Kupczyk D, Bilski R, Kozieł I, Słota A, Kurek M, Stablewska E, Baumgart S, Słomka A, Studzińska R.

Nutrients. 2026 Jul 25;18(15):2436. doi: 10.3390/nu18152436.

Vitamin D and L-Cysteine as Potential Regulators of Adiponectin in Alzheimer's Disease: A Narrative Review

Justin Margret J, Jain SK.

Nutrients. 2026 Jul 26;18(15):2440. doi: 10.3390/nu18152440.

Pharmacological Effects and Molecular Mechanisms of Lignans in the Treatment of Alzheimer's Disease

Sun L, Zhu X, Fan C, Wang Y, Chen Q, Zhang L, Zhang Y, Liu Y.

Molecules. 2026 Jul 24;31(15):2594. doi: 10.3390/molecules31152594.

Distinct roles of AMPA receptor subunits as potential therapeutic targets in Alzheimer's disease

Seo J, Kim K, Park M.

Pharmacol Res. 2026 Sep;231:108394. doi: 10.1016/j.phrs.2026.108394. Epub 2026 Aug 13.

Effects of mindfulness-based exercise on Parkinson's disease and Alzheimer's disease: a systematic review and meta-analysis

Zhang M, Zhang Y, Zhang Z, Jia X, Lei S, Bu N, Wang Y, Bai Y, Wang S.

Front Neurol. 2026 Jul 30;17:1860499. doi: 10.3389/fneur.2026.1860499. eCollection 2026.

Unravelling the phytochemical complexity of neuroprotective plants: a metabolomics approach to Alzheimer's disease

Raj SN, Natnan ME, Lou WP, Mediani A, Tencomnao T, Baharum SN.

Mol Biol Rep. 2026 Aug 14;53(1):1403. doi: 10.1007/s11033-026-12565-5.

Gantenerumab for Early Alzheimer's Disease: An Updated Systematic Review and Meta-Analysis

Javed MN, Khan SM, Mustafa S, Mujtaba A, Amin H, Azhar N, Hameed A, Zayed A, Khalid M, Hussain JM.

Brain Behav. 2026 Aug;16(8):e71643. doi: 10.1002/brb3.71643.

GLP-1 receptor agonists for Alzheimer's disease: Lessons from trials and translational challenges

Stringhi R, Padovani A, Marcello E.

Cell Rep Med. 2026 Aug 18;7(8):102918. doi: 10.1016/j.xcrm.2026.102918.

Beyond the Cochrane review: Re-evaluating anti-amyloid therapy in Alzheimer's disease

Bernath MM, Brosch J, Saykin AJ, Wilcock D, Summanwar D, Willis DR.

Alzheimers Dement. 2026 Aug;22(8):e71769. doi: 10.1002/alz.71769.

Considerations for using amyloid-targeting therapies for the treatment of early symptomatic Alzheimer's disease

Budson AE, Ljubenkov PA, Ritter A, Leahy C, Ramanan VK, Brosch J, Burke A, Matthews BR.

Front Neurol. 2026 Aug 10;17:1863897. doi: 10.3389/fneur.2026.1863897. eCollection 2026.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias